Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - TOTAL RECEIVABLES
Total Receivables OCX - OncoCyte Corporation
484 K
LAST VALUE
-41.96%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR